Cargando…

Impact of reduced exposure to calcineurin inhibitors on the development of de novo DSA: a cohort of non-immunized first kidney graft recipients between 2007 and 2014

BACKGROUND: In low-immunological risk kidney transplant recipients (KTRs), reduced exposure to calcineurin inhibitor (CNI) appears particularly attractive for avoiding adverse events, but may increase the risk of developing de novo Donor Specific Antibodies (dnDSA). METHODS: CNI exposure was retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Girerd, S., Schikowski, J., Girerd, N., Duarte, K., Busby, H., Gambier, N., Ladrière, M., Kessler, M., Frimat, L., Aarnink, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139146/ https://www.ncbi.nlm.nih.gov/pubmed/30219043 http://dx.doi.org/10.1186/s12882-018-1014-2

Ejemplares similares

Prognostic value for long-term graft survival of estimated glomerular filtration rate and proteinuria quantified at 3 months after kidney transplantation
por: Mottola, Clément, et al.
Publicado: (2020)

A de novo monoclonal immunoglobulin deposition disease in a kidney transplant recipient: a case report
por: Savenkoff, Benjamin, et al.
Publicado: (2014)

Association between kidney retransplantation and survival according to age in the French national cohort of dialysis patients
por: Girerd, Sophie, et al.
Publicado: (2022)

Association between Long-Term Change in Arterial Stiffness and Cardiovascular Outcomes in Kidney Transplant Recipients: Insights from the TRANSARTE Study
por: Salib, Madonna, et al.
Publicado: (2022)

Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study
por: Matignon, Marie, et al.
Publicado: (2017)

Differential Treatment Effects for Renal Transplant Recipients With DSA-Positive or DSA-Negative Antibody-Mediated Rejection
por: Koslik, Marius Andreas, et al.
Publicado: (2022)

Intégration dans le parcours patient des transplantés rénaux d’un suivi par télésurveillance–expérimentation ETAPES
por: Ayav, C., et al.
Publicado: (2020)

Levels of Procollagen Type I C-Terminal Pro-Peptide and Galectin-3, Arterial Stiffness Measured By Pulse Wave Velocity, and Cardiovascular Morbidity and Mortality in 44 Patients 2 Years After Kidney Transplantation
por: Salib, Madonna, et al.
Publicado: (2023)

Effect of SARS-CoV-2 Infection on Anti-HLA Antibodies and De Novo DSA Incidence in Lung Transplant Recipients
por: Zajacova, A., et al.
Publicado: (2022)

Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience
por: Lasa-Lázaro, María, et al.
Publicado: (2023)

Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients
por: Bergh, Niklas, et al.
Publicado: (2020)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
por: Peddi, V. Ram, et al.
Publicado: (2023)

Induction therapy in kidney transplant recipients: Description of the practices according to the calendar period from the French multicentric DIVAT cohort
por: Boucquemont, Julie, et al.
Publicado: (2020)

Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial
por: Girerd, Sophie, et al.
Publicado: (2019)

Calcineurin inhibitor toxicity in a renal transplant recipient
por: Charney, Douglas A., et al.
Publicado: (2009)

The effect of calcineurin inhibitors on anthropometric measurements in kidney transplant recipients
por: Sayilar, Emel Isiktas, et al.
Publicado: (2022)

Impact of DSA and immunosuppression minimization on rejection, graft, and patient survival after simultaneous liver–kidney transplantation
por: Dekeyser, Manon, et al.
Publicado: (2022)

Potassium canrenoate in brain-dead organ donors: a randomised controlled clinical trial protocol (CANREO-PMO)
por: Belarif, Lilia, et al.
Publicado: (2023)

Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
por: Ivulich, Steven, et al.
Publicado: (2023)

DSA1.2 - Software Release Plan
Publicado: (July)

DSA2.1 - Quality Assurance Plan
Publicado: (June)

Value of DSA in the Diagnostic Workup of Pulsatile Tinnitus
por: Deuschl, Cornelius, et al.
Publicado: (2015)

Pre-formed DSA and kidney allograft outcomes
por: Yeung, Melissa Y.
Publicado: (2020)

EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial
por: Girerd, Sophie, et al.
Publicado: (2018)

Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation
por: Mai, Hoa Le, et al.
Publicado: (2018)

Everolimus‐facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2‐year results from the subgroup analysis of the TRANSFORM study
por: Watarai, Yoshihiko, et al.
Publicado: (2021)

DSA2.4 - Continuous Integration and Certification Testbeds
Publicado: (July)

DSA1.1 - Software Maintenance and Support Plan
Publicado: (May )

DSA2.2.1 - QA Tools Documentation
Publicado: (June)

DSA2.2.2 - QA Tools Documentation
por: Members of EMI collaboration
Publicado: (Febr)

DSA2.2.3 - QA Tools Documentation
por: Members of EMI collaboration
Publicado: (Febr)

DSA2.3.1 - Periodic QA Reports
Publicado: (July)

DSA2.3.2 - Periodic QA Reports
por: Members of EMI collaboration
Publicado: (Apri)

DSA2.3.3 - Periodic QA Reports
por: Members of EMI collaboration
Publicado: (Apri)

Post-pancreaticoduodenectomy hemorrhage: DSA diagnosis and endovascular treatment
por: Zhou, Tan-Yang, et al.
Publicado: (2017)

CT and DSA for evaluation of spontaneous intracerebral lobar bleedings
por: Altenbernd, Jens-Christian, et al.
Publicado: (2022)

rDSA : an intelligent tool for data science assignments
por: Vittorini, Pierpaolo, et al.
Publicado: (2022)

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
por: Yu, Ji Hyun, et al.
Publicado: (2016)

Comparison of pregnancy outcomes in Dutch kidney recipients with and without calcineurin inhibitor exposure: a retrospective study
por: Koenjer, Lisanne M., et al.
Publicado: (2021)

An Early Immediate Early Protein IE-1–Specific T-Cell Polyfunctionality Is Associated With a Better Control of Cytomegalovirus Reactivation in Kidney Transplantation
por: Dekeyser, Manon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eui2ilvc04i0qmd2o4oomb9gqt